Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma

AIM:To evaluate the effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma(CACG)and acute angle-closure glaucoma(AACG). <p>METHODS: Sixty-eyes of 45 cases with CACG or CACG were randomly divided into two groups. Thirty...

Full description

Bibliographic Details
Main Authors: Qing-Hui Kong, Xiao-Yan Dou, Jiang Guo
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2013-09-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://www.ies.net.cn/cn_publish/2013/9/201309020.pdf
_version_ 1818286323651313664
author Qing-Hui Kong
Xiao-Yan Dou
Jiang Guo
author_facet Qing-Hui Kong
Xiao-Yan Dou
Jiang Guo
author_sort Qing-Hui Kong
collection DOAJ
description AIM:To evaluate the effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma(CACG)and acute angle-closure glaucoma(AACG). <p>METHODS: Sixty-eyes of 45 cases with CACG or CACG were randomly divided into two groups. Thirty-four eyes in IOL group underwent phacoemulsification plus intraocular lens(IOL)implantation. Twenty-six eyes in laser iridotomy(LI)group included treatment by LI. Intraocular pressure(IOP), numbers of antiglaucoma medications, complications, and corneal endothelial cell counts were examined in each group. <p>RESULTS: In IOL group, IOP was significantly reduced from a preoperative mean of 14.82±4.23mmHg to a 6-month postoperative mean of 10.94±1.24mmHg. However, in LI group, mean preoperative IOP was 15.34±4.13mmHg, and the 6-month postoperative IOP was 14.68±4.77mmHg. There was statistical significance in preoperative and postoperative IOP between two groups(<i>F</i>=36.452, <i>P</i><0.01). In IOL group, no patient used anti-glaucoma medications 6-month postoperatively, whereas in LI group, mean number of anti-glaucoma medications was 0.24±0.41(<i>P</i><0.05). There were no significant differences in preoperative and postoperative corneal endothelial cell counts between IOL and LI groups(<i>P</i>>0.05). <p>CONCLUSION: Primary phacoemulsification plus intraocular lens implantation for controlled CACG or AACG seems to be a safe and effective method in reducing IOP. This procedure might become the first treatment of choice for controlled CACG or AACG with cataract.
first_indexed 2024-12-13T01:22:42Z
format Article
id doaj.art-d8ca50460a9e4d338032b49dd6e633a9
institution Directory Open Access Journal
issn 1672-5123
language English
last_indexed 2024-12-13T01:22:42Z
publishDate 2013-09-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series Guoji Yanke Zazhi
spelling doaj.art-d8ca50460a9e4d338032b49dd6e633a92022-12-22T00:04:12ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232013-09-011391807180910.3980/j.issn.1672-5123.2013.09.20Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucomaQing-Hui KongXiao-Yan DouJiang GuoAIM:To evaluate the effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma(CACG)and acute angle-closure glaucoma(AACG). <p>METHODS: Sixty-eyes of 45 cases with CACG or CACG were randomly divided into two groups. Thirty-four eyes in IOL group underwent phacoemulsification plus intraocular lens(IOL)implantation. Twenty-six eyes in laser iridotomy(LI)group included treatment by LI. Intraocular pressure(IOP), numbers of antiglaucoma medications, complications, and corneal endothelial cell counts were examined in each group. <p>RESULTS: In IOL group, IOP was significantly reduced from a preoperative mean of 14.82±4.23mmHg to a 6-month postoperative mean of 10.94±1.24mmHg. However, in LI group, mean preoperative IOP was 15.34±4.13mmHg, and the 6-month postoperative IOP was 14.68±4.77mmHg. There was statistical significance in preoperative and postoperative IOP between two groups(<i>F</i>=36.452, <i>P</i><0.01). In IOL group, no patient used anti-glaucoma medications 6-month postoperatively, whereas in LI group, mean number of anti-glaucoma medications was 0.24±0.41(<i>P</i><0.05). There were no significant differences in preoperative and postoperative corneal endothelial cell counts between IOL and LI groups(<i>P</i>>0.05). <p>CONCLUSION: Primary phacoemulsification plus intraocular lens implantation for controlled CACG or AACG seems to be a safe and effective method in reducing IOP. This procedure might become the first treatment of choice for controlled CACG or AACG with cataract.http://www.ies.net.cn/cn_publish/2013/9/201309020.pdfcataract phacoemulsificationintraocular lens implantationprimary angle-closure glaucoma
spellingShingle Qing-Hui Kong
Xiao-Yan Dou
Jiang Guo
Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
Guoji Yanke Zazhi
cataract phacoemulsification
intraocular lens implantation
primary angle-closure glaucoma
title Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
title_full Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
title_fullStr Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
title_full_unstemmed Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
title_short Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
title_sort clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle closure glaucoma
topic cataract phacoemulsification
intraocular lens implantation
primary angle-closure glaucoma
url http://www.ies.net.cn/cn_publish/2013/9/201309020.pdf
work_keys_str_mv AT qinghuikong clinicalobservationofprimaryphacoemulsificationplusintraocularlensimplantationforprimaryangleclosureglaucoma
AT xiaoyandou clinicalobservationofprimaryphacoemulsificationplusintraocularlensimplantationforprimaryangleclosureglaucoma
AT jiangguo clinicalobservationofprimaryphacoemulsificationplusintraocularlensimplantationforprimaryangleclosureglaucoma